ROCKET PHARMACEUTICALS INC's ticker is RCKT and the CUSIP is 77313F106. A total of 177 filers reported holding ROCKET PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 1.35 and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $541,741 | -2.0% | 27,709 | 0.0% | 0.11% | -9.0% |
Q2 2023 | $553,072 | +2.0% | 27,709 | 0.0% | 0.12% | -40.5% |
Q4 2022 | $542,265 | +26.1% | 27,709 | 0.0% | 0.20% | +95.2% |
Q3 2022 | $430,000 | +7.5% | 27,709 | 0.0% | 0.10% | +19.3% |
Q2 2022 | $400,000 | -8.9% | 27,709 | 0.0% | 0.09% | +2.3% |
Q1 2022 | $439,000 | -32.0% | 27,709 | 0.0% | 0.09% | -23.2% |
Q4 2021 | $646,000 | -21.6% | 27,709 | 0.0% | 0.11% | -25.3% |
Q3 2021 | $824,000 | -34.3% | 27,709 | 0.0% | 0.15% | -38.5% |
Q2 2021 | $1,255,000 | +7.9% | 27,709 | 0.0% | 0.24% | -0.8% |
Q1 2021 | $1,163,000 | -24.4% | 27,709 | 0.0% | 0.25% | -29.7% |
Q4 2020 | $1,538,000 | +99.2% | 27,709 | 0.0% | 0.35% | +66.7% |
Q3 2020 | $772,000 | – | 27,709 | – | 0.21% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
M28 Capital Management LP | 715,880 | $9,851,000 | 11.04% |
RTW INVESTMENTS, LP | 15,802,802 | $217,447,000 | 5.62% |
Amitell Capital Pte Ltd | 97,331 | $1,339,000 | 3.05% |
Prosight Management, LP | 276,802 | $3,809,000 | 3.00% |
TANG CAPITAL MANAGEMENT LLC | 1,265,900 | $17,419,000 | 2.64% |
Affinity Asset Advisors, LLC | 250,466 | $3,446,000 | 1.45% |
COWEN AND COMPANY, LLC | 1,000,000 | $13,760,000 | 1.33% |
Boxer Capital, LLC | 1,466,051 | $20,173,000 | 1.28% |
Cormorant Asset Management, LP | 868,550 | $11,951,000 | 0.90% |
MAVERICK CAPITAL LTD | 2,532,366 | $34,845,000 | 0.86% |